Literature DB >> 35622252

Neurotrophin-3 Enhances the Effectiveness of Cell Therapy in Chronic Spinal Cord Injuries.

O V Stepanova1,2, A D Voronova3, A V Chadin3, G A Fursa3,4, E K Karsuntseva3, M P Valikhov3,5, A S Semkina3,6, I V Reshetov7, V P Chekhonin3,6.   

Abstract

Neurotrophin-3 enhances the effectiveness of human olfactory ensheathing cells in improving hind limb mobility in rats with post-traumatic cysts of the spinal cord. Transplantation of olfactory ensheathing cells into spinal cord cysts reduced their size; neurotrophin-3 did not modulate this effect. Combined preparation of human olfactory ensheathing cells and neurotrophin- 3 can be used in neurosurgery for the treatment of patients with spinal cord injuries.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  cell therapy; human olfactory ensheathing cells; neurotrophin-3; olfactory mucosa; spinal cord injury

Mesh：

Substances：

Year:  2022        PMID： 35622252     DOI： 10.1007/s10517-022-05504-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  19 in total

Review 1.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.

Authors:  L L Jones; M Oudega; M B Bunge; M H Tuszynski
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

2.  Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue.

Authors:  Bas Blits; Brandon M Kitay; Arash Farahvar; Caroline V Caperton; W Dalton Dietrich; Mary Bartlett Bunge
Journal:  Restor Neurol Neurosci       Date:  2005       Impact factor: 2.406

3.  Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury.

Authors:  Yu-Hai Ma; Yong Zhang; Li Cao; Jia-Can Su; Zhi-Wei Wang; A-Bing Xu; Shao-Cheng Zhang
Journal:  Cell Transplant       Date:  2010-03-26       Impact factor: 4.064

4.  Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration?

Authors:  Yatma Gueye; Lotfi Ferhat; Oualid Sbai; John Bianco; Adlane Ould-Yahoui; Anne Bernard; Eliane Charrat; Jean-Paul Chauvin; Jean-Jacques Risso; François Féron; Santiago Rivera; Michel Khrestchatisky
Journal:  Glia       Date:  2011-02-28       Impact factor: 7.452

Review 5.  Cell Transplantation and Neuroengineering Approach for Spinal Cord Injury Treatment: A Summary of Current Laboratory Findings and Review of Literature.

Authors:  Xin-Yi Lin; Bi-Qin Lai; Xiang Zeng; Ming-Tian Che; Eng-Ang Ling; Wutian Wu; Yuan-Shan Zeng
Journal:  Cell Transplant       Date:  2016-02-02       Impact factor: 4.064

Review 6.  Recovery and regeneration after spinal cord injury: a review and summary of recent literature.

Authors:  Peter A C Lim; Adela M Tow
Journal:  Ann Acad Med Singapore       Date:  2007-01       Impact factor: 2.473

7.  Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose.

Authors:  John I Bianco; Chris Perry; Damien G Harkin; Alan Mackay-Sim; François Féron
Journal:  Glia       Date:  2004-01-15       Impact factor: 7.452

Review 8.  NGF, BDNF, NT3, and NT4.

Authors:  M Bothwell
Journal:  Handb Exp Pharmacol       Date:  2014

Review 9.  Translational potential of olfactory mucosa for the study of neuropsychiatric illness.

Authors:  K Borgmann-Winter; S L Willard; D Sinclair; N Mirza; B Turetsky; S Berretta; C-G Hahn
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

Review 10.  Transplantation of olfactory ensheathing cells on functional recovery and neuropathic pain after spinal cord injury; systematic review and meta-analysis.

Authors:  Babak Nakhjavan-Shahraki; Mahmoud Yousefifard; Vafa Rahimi-Movaghar; Masoud Baikpour; Farinaz Nasirinezhad; Saeed Safari; Mehdi Yaseri; Ali Moghadas Jafari; Parisa Ghelichkhani; Abbas Tafakhori; Mostafa Hosseini
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.